Aplastic Anemia
Antithymocyte globulin and cyclosporine can lead to Merkel cell carcinoma
Published in Blood Weekly, June 5th, 2003
According to published research from Japan, "We report a patient who developed Merkel cell carcinoma (MCC) after treatment with antithymocyte globulin and cyclosporine for aplastic anemia.
The clinical course was progressive and prognosis poor," wrote M. Takabayashi and colleagues.
The researchers concluded: "Although MCC is relatively rare in second cancers arising after immunosuppressive therapy, patients should be closely monitored for the development of this complication as well as other second malignancies."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2003-06-05)
More Articles from Blood Weekly
- Chronic Myelogenous Leukemia
Oncogene-expressing stem cells downregulate tumor suppressor BRCA1 - Stem Cell Transplantation
Nonmyeloablative conditioning enables marrow-induced tolerance - Acute Lymphoblastic Leukemia
Intensified GVHD prophylaxis enables haploidentical stem cell transplants - Hematology
Postnatal bone marrow stromal cells could stimulate therapeutic angiogenesis - Stem Cell Research
Pumilio proteins expressed by murine hematopoietic cells - Stem Cell Research
Adult bone marrow only reliable source of mesenchymal stem cells - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
